nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—ABCG2—epilepsy syndrome	0.183	0.706	CbGaD
Mitoxantrone—ABCB1—epilepsy syndrome	0.0763	0.294	CbGaD
Mitoxantrone—CYP1B1—Propofol—epilepsy syndrome	0.0457	0.1	CbGbCtD
Mitoxantrone—CYP1B1—Phenobarbital—epilepsy syndrome	0.0436	0.0957	CbGbCtD
Mitoxantrone—ABCC1—Phenobarbital—epilepsy syndrome	0.031	0.068	CbGbCtD
Mitoxantrone—CYP2E1—Felbamate—epilepsy syndrome	0.0274	0.0601	CbGbCtD
Mitoxantrone—CYP2E1—Trimethadione—epilepsy syndrome	0.0274	0.0601	CbGbCtD
Mitoxantrone—CYP2E1—Clonazepam—epilepsy syndrome	0.0233	0.0511	CbGbCtD
Mitoxantrone—CYP2E1—Rufinamide—epilepsy syndrome	0.019	0.0416	CbGbCtD
Mitoxantrone—ABCB1—Levetiracetam—epilepsy syndrome	0.0163	0.0357	CbGbCtD
Mitoxantrone—CYP2E1—Propofol—epilepsy syndrome	0.0155	0.0339	CbGbCtD
Mitoxantrone—CYP2E1—Phenobarbital—epilepsy syndrome	0.0148	0.0324	CbGbCtD
Mitoxantrone—CYP2E1—Midazolam—epilepsy syndrome	0.0146	0.032	CbGbCtD
Mitoxantrone—CYP2E1—Diazepam—epilepsy syndrome	0.014	0.0307	CbGbCtD
Mitoxantrone—ABCB1—Clobazam—epilepsy syndrome	0.0113	0.0248	CbGbCtD
Mitoxantrone—ABCB1—Lamotrigine—epilepsy syndrome	0.0109	0.0238	CbGbCtD
Mitoxantrone—ABCB1—Carbamazepine—epilepsy syndrome	0.00936	0.0205	CbGbCtD
Mitoxantrone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00893	0.0196	CbGbCtD
Mitoxantrone—ABCB1—Phenytoin—epilepsy syndrome	0.00839	0.0184	CbGbCtD
Mitoxantrone—CYP3A4—Felbamate—epilepsy syndrome	0.0083	0.0182	CbGbCtD
Mitoxantrone—CYP3A4—Trimethadione—epilepsy syndrome	0.0083	0.0182	CbGbCtD
Mitoxantrone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0078	0.0171	CbGbCtD
Mitoxantrone—ABCB1—Phenobarbital—epilepsy syndrome	0.00748	0.0164	CbGbCtD
Mitoxantrone—ABCB1—Midazolam—epilepsy syndrome	0.00738	0.0162	CbGbCtD
Mitoxantrone—ABCB1—Diazepam—epilepsy syndrome	0.00709	0.0155	CbGbCtD
Mitoxantrone—CYP3A4—Clonazepam—epilepsy syndrome	0.00706	0.0155	CbGbCtD
Mitoxantrone—CYP3A4—Clobazam—epilepsy syndrome	0.00677	0.0148	CbGbCtD
Mitoxantrone—CYP3A4—Rufinamide—epilepsy syndrome	0.00575	0.0126	CbGbCtD
Mitoxantrone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00561	0.0123	CbGbCtD
Mitoxantrone—CYP3A4—Primidone—epilepsy syndrome	0.00523	0.0115	CbGbCtD
Mitoxantrone—CYP3A4—Phenytoin—epilepsy syndrome	0.00503	0.011	CbGbCtD
Mitoxantrone—CYP3A4—Propofol—epilepsy syndrome	0.00469	0.0103	CbGbCtD
Mitoxantrone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00448	0.00983	CbGbCtD
Mitoxantrone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00448	0.00983	CbGbCtD
Mitoxantrone—CYP3A4—Midazolam—epilepsy syndrome	0.00442	0.00969	CbGbCtD
Mitoxantrone—CYP3A4—Diazepam—epilepsy syndrome	0.00425	0.00932	CbGbCtD
Mitoxantrone—CYP3A4—Zonisamide—epilepsy syndrome	0.00415	0.00909	CbGbCtD
Mitoxantrone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00335	0.00734	CbGbCtD
Mitoxantrone—CYP3A4—Topiramate—epilepsy syndrome	0.00302	0.00663	CbGbCtD
Mitoxantrone—TOP2A—Pyrimethamine—Lamotrigine—epilepsy syndrome	0.00168	0.768	CbGdCrCtD
Mitoxantrone—PIM1—forebrain—epilepsy syndrome	0.00129	0.0501	CbGeAlD
Mitoxantrone—SLC47A1—hindbrain—epilepsy syndrome	0.00125	0.0485	CbGeAlD
Mitoxantrone—SLC47A2—head—epilepsy syndrome	0.00113	0.0439	CbGeAlD
Mitoxantrone—BTK—medulla oblongata—epilepsy syndrome	0.00108	0.0418	CbGeAlD
Mitoxantrone—SLC47A2—nervous system—epilepsy syndrome	0.00107	0.0416	CbGeAlD
Mitoxantrone—SLC47A2—central nervous system—epilepsy syndrome	0.00103	0.0401	CbGeAlD
Mitoxantrone—BTK—spinal cord—epilepsy syndrome	0.000959	0.0373	CbGeAlD
Mitoxantrone—PIM1—medulla oblongata—epilepsy syndrome	0.000932	0.0362	CbGeAlD
Mitoxantrone—PIM1—midbrain—epilepsy syndrome	0.000852	0.0331	CbGeAlD
Mitoxantrone—PIM1—spinal cord—epilepsy syndrome	0.000831	0.0323	CbGeAlD
Mitoxantrone—SLC47A2—brain—epilepsy syndrome	0.000819	0.0318	CbGeAlD
Mitoxantrone—PIM1—head—epilepsy syndrome	0.000739	0.0287	CbGeAlD
Mitoxantrone—SLC47A1—brainstem—epilepsy syndrome	0.000716	0.0278	CbGeAlD
Mitoxantrone—PIM1—nervous system—epilepsy syndrome	0.0007	0.0272	CbGeAlD
Mitoxantrone—PIM1—central nervous system—epilepsy syndrome	0.000674	0.0262	CbGeAlD
Mitoxantrone—PIM1—cerebellum—epilepsy syndrome	0.000659	0.0256	CbGeAlD
Mitoxantrone—BTK—brain—epilepsy syndrome	0.000618	0.024	CbGeAlD
Mitoxantrone—PIM1—brain—epilepsy syndrome	0.000535	0.0208	CbGeAlD
Mitoxantrone—SLC47A1—medulla oblongata—epilepsy syndrome	0.000499	0.0194	CbGeAlD
Mitoxantrone—CYP1B1—telencephalon—epilepsy syndrome	0.000466	0.0181	CbGeAlD
Mitoxantrone—SLC47A1—spinal cord—epilepsy syndrome	0.000445	0.0173	CbGeAlD
Mitoxantrone—ABCC1—telencephalon—epilepsy syndrome	0.000419	0.0163	CbGeAlD
Mitoxantrone—SLC47A1—head—epilepsy syndrome	0.000396	0.0154	CbGeAlD
Mitoxantrone—SLC47A1—nervous system—epilepsy syndrome	0.000375	0.0146	CbGeAlD
Mitoxantrone—SLC47A1—central nervous system—epilepsy syndrome	0.000361	0.014	CbGeAlD
Mitoxantrone—SLC47A1—cerebellum—epilepsy syndrome	0.000353	0.0137	CbGeAlD
Mitoxantrone—ABCG2—telencephalon—epilepsy syndrome	0.000347	0.0135	CbGeAlD
Mitoxantrone—CYP2E1—telencephalon—epilepsy syndrome	0.0003	0.0117	CbGeAlD
Mitoxantrone—CYP1B1—head—epilepsy syndrome	0.00029	0.0113	CbGeAlD
Mitoxantrone—SLC47A1—brain—epilepsy syndrome	0.000287	0.0111	CbGeAlD
Mitoxantrone—CYP1B1—nervous system—epilepsy syndrome	0.000275	0.0107	CbGeAlD
Mitoxantrone—ABCG2—medulla oblongata—epilepsy syndrome	0.000273	0.0106	CbGeAlD
Mitoxantrone—CYP1B1—central nervous system—epilepsy syndrome	0.000265	0.0103	CbGeAlD
Mitoxantrone—CYP1B1—cerebellum—epilepsy syndrome	0.000259	0.0101	CbGeAlD
Mitoxantrone—ABCG2—midbrain—epilepsy syndrome	0.000249	0.00968	CbGeAlD
Mitoxantrone—ABCG2—spinal cord—epilepsy syndrome	0.000243	0.00944	CbGeAlD
Mitoxantrone—CYP2E1—medulla oblongata—epilepsy syndrome	0.000236	0.00917	CbGeAlD
Mitoxantrone—ABCC1—cerebellum—epilepsy syndrome	0.000233	0.00904	CbGeAlD
Mitoxantrone—TOP2A—Bortezomib—Lacosamide—epilepsy syndrome	0.000221	0.101	CbGdCrCtD
Mitoxantrone—CYP2E1—spinal cord—epilepsy syndrome	0.00021	0.00817	CbGeAlD
Mitoxantrone—CYP1B1—brain—epilepsy syndrome	0.00021	0.00816	CbGeAlD
Mitoxantrone—ABCG2—cerebellum—epilepsy syndrome	0.000193	0.00749	CbGeAlD
Mitoxantrone—ABCC1—brain—epilepsy syndrome	0.000189	0.00734	CbGeAlD
Mitoxantrone—CYP2E1—head—epilepsy syndrome	0.000187	0.00726	CbGeAlD
Mitoxantrone—ABCB1—forebrain—epilepsy syndrome	0.000186	0.00723	CbGeAlD
Mitoxantrone—CYP2E1—nervous system—epilepsy syndrome	0.000177	0.00689	CbGeAlD
Mitoxantrone—ABCB1—telencephalon—epilepsy syndrome	0.000171	0.00664	CbGeAlD
Mitoxantrone—CYP2E1—central nervous system—epilepsy syndrome	0.000171	0.00663	CbGeAlD
Mitoxantrone—CYP2E1—cerebellum—epilepsy syndrome	0.000167	0.00648	CbGeAlD
Mitoxantrone—ABCG2—brain—epilepsy syndrome	0.000157	0.00608	CbGeAlD
Mitoxantrone—TOP2A—Niclosamide—Clonazepam—epilepsy syndrome	0.000153	0.0703	CbGdCrCtD
Mitoxantrone—CYP3A4—nervous system—epilepsy syndrome	0.000143	0.00554	CbGeAlD
Mitoxantrone—CYP3A4—central nervous system—epilepsy syndrome	0.000137	0.00533	CbGeAlD
Mitoxantrone—CYP2E1—brain—epilepsy syndrome	0.000136	0.00526	CbGeAlD
Mitoxantrone—ABCB1—medulla oblongata—epilepsy syndrome	0.000134	0.00522	CbGeAlD
Mitoxantrone—TOP2A—Chlorpromazine—Clobazam—epilepsy syndrome	0.000132	0.0602	CbGdCrCtD
Mitoxantrone—ABCB1—midbrain—epilepsy syndrome	0.000123	0.00477	CbGeAlD
Mitoxantrone—ABCB1—spinal cord—epilepsy syndrome	0.00012	0.00465	CbGeAlD
Mitoxantrone—ABCB1—head—epilepsy syndrome	0.000107	0.00414	CbGeAlD
Mitoxantrone—ABCB1—nervous system—epilepsy syndrome	0.000101	0.00392	CbGeAlD
Mitoxantrone—ABCB1—central nervous system—epilepsy syndrome	9.72e-05	0.00378	CbGeAlD
Mitoxantrone—ABCB1—cerebellum—epilepsy syndrome	9.5e-05	0.00369	CbGeAlD
Mitoxantrone—ABCB1—brain—epilepsy syndrome	7.72e-05	0.003	CbGeAlD
Mitoxantrone—Confusional state—Valproic Acid—epilepsy syndrome	5.84e-05	0.000335	CcSEcCtD
Mitoxantrone—Hypersensitivity—Phenytoin—epilepsy syndrome	5.82e-05	0.000334	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Valproic Acid—epilepsy syndrome	5.79e-05	0.000332	CcSEcCtD
Mitoxantrone—Oedema—Valproic Acid—epilepsy syndrome	5.79e-05	0.000332	CcSEcCtD
Mitoxantrone—Urticaria—Lamotrigine—epilepsy syndrome	5.79e-05	0.000332	CcSEcCtD
Mitoxantrone—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.79e-05	0.000332	CcSEcCtD
Mitoxantrone—Bradycardia—Topiramate—epilepsy syndrome	5.79e-05	0.000332	CcSEcCtD
Mitoxantrone—Malaise—Pregabalin—epilepsy syndrome	5.79e-05	0.000332	CcSEcCtD
Mitoxantrone—Nausea—Propofol—epilepsy syndrome	5.79e-05	0.000332	CcSEcCtD
Mitoxantrone—Vomiting—Fosphenytoin—epilepsy syndrome	5.77e-05	0.000331	CcSEcCtD
Mitoxantrone—Diarrhoea—Felbamate—epilepsy syndrome	5.77e-05	0.000331	CcSEcCtD
Mitoxantrone—Abdominal pain—Lamotrigine—epilepsy syndrome	5.76e-05	0.000331	CcSEcCtD
Mitoxantrone—Body temperature increased—Lamotrigine—epilepsy syndrome	5.76e-05	0.000331	CcSEcCtD
Mitoxantrone—Dysgeusia—Gabapentin—epilepsy syndrome	5.76e-05	0.000331	CcSEcCtD
Mitoxantrone—Infection—Valproic Acid—epilepsy syndrome	5.76e-05	0.00033	CcSEcCtD
Mitoxantrone—Leukopenia—Pregabalin—epilepsy syndrome	5.75e-05	0.00033	CcSEcCtD
Mitoxantrone—Rash—Fosphenytoin—epilepsy syndrome	5.73e-05	0.000329	CcSEcCtD
Mitoxantrone—Dermatitis—Fosphenytoin—epilepsy syndrome	5.72e-05	0.000328	CcSEcCtD
Mitoxantrone—Haemoglobin—Topiramate—epilepsy syndrome	5.72e-05	0.000328	CcSEcCtD
Mitoxantrone—Asthenia—Clonazepam—epilepsy syndrome	5.71e-05	0.000328	CcSEcCtD
Mitoxantrone—Rhinitis—Topiramate—epilepsy syndrome	5.7e-05	0.000327	CcSEcCtD
Mitoxantrone—Back pain—Gabapentin—epilepsy syndrome	5.69e-05	0.000327	CcSEcCtD
Mitoxantrone—Headache—Fosphenytoin—epilepsy syndrome	5.69e-05	0.000326	CcSEcCtD
Mitoxantrone—Haemorrhage—Topiramate—epilepsy syndrome	5.69e-05	0.000326	CcSEcCtD
Mitoxantrone—Hepatitis—Topiramate—epilepsy syndrome	5.69e-05	0.000326	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Valproic Acid—epilepsy syndrome	5.67e-05	0.000326	CcSEcCtD
Mitoxantrone—Asthenia—Phenytoin—epilepsy syndrome	5.67e-05	0.000325	CcSEcCtD
Mitoxantrone—Nausea—Midazolam—epilepsy syndrome	5.66e-05	0.000325	CcSEcCtD
Mitoxantrone—Tachycardia—Valproic Acid—epilepsy syndrome	5.66e-05	0.000325	CcSEcCtD
Mitoxantrone—Diarrhoea—Zonisamide—epilepsy syndrome	5.65e-05	0.000324	CcSEcCtD
Mitoxantrone—Pharyngitis—Topiramate—epilepsy syndrome	5.65e-05	0.000324	CcSEcCtD
Mitoxantrone—Asthenia—Oxcarbazepine—epilepsy syndrome	5.64e-05	0.000324	CcSEcCtD
Mitoxantrone—Vomiting—Vigabatrin—epilepsy syndrome	5.63e-05	0.000323	CcSEcCtD
Mitoxantrone—Skin disorder—Valproic Acid—epilepsy syndrome	5.63e-05	0.000323	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.6e-05	0.000321	CcSEcCtD
Mitoxantrone—Cough—Pregabalin—epilepsy syndrome	5.6e-05	0.000321	CcSEcCtD
Mitoxantrone—Nausea—Levetiracetam—epilepsy syndrome	5.59e-05	0.000321	CcSEcCtD
Mitoxantrone—Rash—Vigabatrin—epilepsy syndrome	5.58e-05	0.00032	CcSEcCtD
Mitoxantrone—Dermatitis—Vigabatrin—epilepsy syndrome	5.58e-05	0.00032	CcSEcCtD
Mitoxantrone—Convulsion—Pregabalin—epilepsy syndrome	5.56e-05	0.000319	CcSEcCtD
Mitoxantrone—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.56e-05	0.000319	CcSEcCtD
Mitoxantrone—Vision blurred—Gabapentin—epilepsy syndrome	5.55e-05	0.000318	CcSEcCtD
Mitoxantrone—Headache—Vigabatrin—epilepsy syndrome	5.55e-05	0.000318	CcSEcCtD
Mitoxantrone—Hypertension—Pregabalin—epilepsy syndrome	5.54e-05	0.000318	CcSEcCtD
Mitoxantrone—Vomiting—Diazepam—epilepsy syndrome	5.54e-05	0.000318	CcSEcCtD
Mitoxantrone—Anorexia—Valproic Acid—epilepsy syndrome	5.52e-05	0.000317	CcSEcCtD
Mitoxantrone—Rash—Diazepam—epilepsy syndrome	5.5e-05	0.000315	CcSEcCtD
Mitoxantrone—Dermatitis—Diazepam—epilepsy syndrome	5.49e-05	0.000315	CcSEcCtD
Mitoxantrone—Chest pain—Pregabalin—epilepsy syndrome	5.46e-05	0.000314	CcSEcCtD
Mitoxantrone—Arthralgia—Pregabalin—epilepsy syndrome	5.46e-05	0.000314	CcSEcCtD
Mitoxantrone—Myalgia—Pregabalin—epilepsy syndrome	5.46e-05	0.000314	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.46e-05	0.000313	CcSEcCtD
Mitoxantrone—Headache—Diazepam—epilepsy syndrome	5.46e-05	0.000313	CcSEcCtD
Mitoxantrone—Anxiety—Pregabalin—epilepsy syndrome	5.45e-05	0.000312	CcSEcCtD
Mitoxantrone—Diarrhoea—Clonazepam—epilepsy syndrome	5.44e-05	0.000312	CcSEcCtD
Mitoxantrone—Anaemia—Gabapentin—epilepsy syndrome	5.44e-05	0.000312	CcSEcCtD
Mitoxantrone—Hypotension—Valproic Acid—epilepsy syndrome	5.41e-05	0.000311	CcSEcCtD
Mitoxantrone—Asthenia—Carbamazepine—epilepsy syndrome	5.41e-05	0.000311	CcSEcCtD
Mitoxantrone—Diarrhoea—Phenytoin—epilepsy syndrome	5.41e-05	0.00031	CcSEcCtD
Mitoxantrone—Discomfort—Pregabalin—epilepsy syndrome	5.4e-05	0.00031	CcSEcCtD
Mitoxantrone—Nausea—Fosphenytoin—epilepsy syndrome	5.39e-05	0.00031	CcSEcCtD
Mitoxantrone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.38e-05	0.000309	CcSEcCtD
Mitoxantrone—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.37e-05	0.000308	CcSEcCtD
Mitoxantrone—Vomiting—Felbamate—epilepsy syndrome	5.36e-05	0.000308	CcSEcCtD
Mitoxantrone—Rash—Felbamate—epilepsy syndrome	5.32e-05	0.000305	CcSEcCtD
Mitoxantrone—Dermatitis—Felbamate—epilepsy syndrome	5.31e-05	0.000305	CcSEcCtD
Mitoxantrone—Malaise—Gabapentin—epilepsy syndrome	5.31e-05	0.000305	CcSEcCtD
Mitoxantrone—Headache—Felbamate—epilepsy syndrome	5.28e-05	0.000303	CcSEcCtD
Mitoxantrone—Confusional state—Pregabalin—epilepsy syndrome	5.28e-05	0.000303	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.28e-05	0.000303	CcSEcCtD
Mitoxantrone—Leukopenia—Gabapentin—epilepsy syndrome	5.27e-05	0.000302	CcSEcCtD
Mitoxantrone—Nausea—Vigabatrin—epilepsy syndrome	5.26e-05	0.000302	CcSEcCtD
Mitoxantrone—Vomiting—Zonisamide—epilepsy syndrome	5.25e-05	0.000301	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.24e-05	0.000301	CcSEcCtD
Mitoxantrone—Oedema—Pregabalin—epilepsy syndrome	5.24e-05	0.000301	CcSEcCtD
Mitoxantrone—Asthenia—Lamotrigine—epilepsy syndrome	5.23e-05	0.0003	CcSEcCtD
Mitoxantrone—Rash—Zonisamide—epilepsy syndrome	5.21e-05	0.000299	CcSEcCtD
Mitoxantrone—Infection—Pregabalin—epilepsy syndrome	5.2e-05	0.000299	CcSEcCtD
Mitoxantrone—Paraesthesia—Valproic Acid—epilepsy syndrome	5.2e-05	0.000299	CcSEcCtD
Mitoxantrone—Dermatitis—Zonisamide—epilepsy syndrome	5.2e-05	0.000298	CcSEcCtD
Mitoxantrone—Nausea—Diazepam—epilepsy syndrome	5.18e-05	0.000297	CcSEcCtD
Mitoxantrone—Headache—Zonisamide—epilepsy syndrome	5.17e-05	0.000297	CcSEcCtD
Mitoxantrone—Dyspnoea—Valproic Acid—epilepsy syndrome	5.17e-05	0.000296	CcSEcCtD
Mitoxantrone—Diarrhoea—Carbamazepine—epilepsy syndrome	5.16e-05	0.000296	CcSEcCtD
Mitoxantrone—Shock—Pregabalin—epilepsy syndrome	5.15e-05	0.000296	CcSEcCtD
Mitoxantrone—Somnolence—Valproic Acid—epilepsy syndrome	5.15e-05	0.000296	CcSEcCtD
Mitoxantrone—Cough—Gabapentin—epilepsy syndrome	5.14e-05	0.000295	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.13e-05	0.000294	CcSEcCtD
Mitoxantrone—Tachycardia—Pregabalin—epilepsy syndrome	5.11e-05	0.000293	CcSEcCtD
Mitoxantrone—Chills—Topiramate—epilepsy syndrome	5.1e-05	0.000293	CcSEcCtD
Mitoxantrone—Dyspepsia—Valproic Acid—epilepsy syndrome	5.1e-05	0.000293	CcSEcCtD
Mitoxantrone—Convulsion—Gabapentin—epilepsy syndrome	5.1e-05	0.000293	CcSEcCtD
Mitoxantrone—Skin disorder—Pregabalin—epilepsy syndrome	5.09e-05	0.000292	CcSEcCtD
Mitoxantrone—Hypertension—Gabapentin—epilepsy syndrome	5.08e-05	0.000292	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.06e-05	0.000291	CcSEcCtD
Mitoxantrone—Vomiting—Clonazepam—epilepsy syndrome	5.06e-05	0.00029	CcSEcCtD
Mitoxantrone—Decreased appetite—Valproic Acid—epilepsy syndrome	5.04e-05	0.000289	CcSEcCtD
Mitoxantrone—Alopecia—Topiramate—epilepsy syndrome	5.03e-05	0.000288	CcSEcCtD
Mitoxantrone—Vomiting—Phenytoin—epilepsy syndrome	5.03e-05	0.000288	CcSEcCtD
Mitoxantrone—Rash—Clonazepam—epilepsy syndrome	5.02e-05	0.000288	CcSEcCtD
Mitoxantrone—Dermatitis—Clonazepam—epilepsy syndrome	5.01e-05	0.000288	CcSEcCtD
Mitoxantrone—Chest pain—Gabapentin—epilepsy syndrome	5.01e-05	0.000288	CcSEcCtD
Mitoxantrone—Myalgia—Gabapentin—epilepsy syndrome	5.01e-05	0.000288	CcSEcCtD
Mitoxantrone—Arthralgia—Gabapentin—epilepsy syndrome	5.01e-05	0.000288	CcSEcCtD
Mitoxantrone—Nausea—Felbamate—epilepsy syndrome	5.01e-05	0.000288	CcSEcCtD
Mitoxantrone—Vomiting—Oxcarbazepine—epilepsy syndrome	5e-05	0.000287	CcSEcCtD
Mitoxantrone—Fatigue—Valproic Acid—epilepsy syndrome	5e-05	0.000287	CcSEcCtD
Mitoxantrone—Anxiety—Gabapentin—epilepsy syndrome	4.99e-05	0.000287	CcSEcCtD
Mitoxantrone—Anorexia—Pregabalin—epilepsy syndrome	4.99e-05	0.000287	CcSEcCtD
Mitoxantrone—Diarrhoea—Lamotrigine—epilepsy syndrome	4.99e-05	0.000286	CcSEcCtD
Mitoxantrone—Headache—Clonazepam—epilepsy syndrome	4.99e-05	0.000286	CcSEcCtD
Mitoxantrone—Rash—Phenytoin—epilepsy syndrome	4.98e-05	0.000286	CcSEcCtD
Mitoxantrone—Dermatitis—Phenytoin—epilepsy syndrome	4.98e-05	0.000286	CcSEcCtD
Mitoxantrone—Rash—Oxcarbazepine—epilepsy syndrome	4.96e-05	0.000284	CcSEcCtD
Mitoxantrone—Pain—Valproic Acid—epilepsy syndrome	4.96e-05	0.000284	CcSEcCtD
Mitoxantrone—Constipation—Valproic Acid—epilepsy syndrome	4.96e-05	0.000284	CcSEcCtD
Mitoxantrone—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.95e-05	0.000284	CcSEcCtD
Mitoxantrone—Headache—Phenytoin—epilepsy syndrome	4.95e-05	0.000284	CcSEcCtD
Mitoxantrone—Erythema—Topiramate—epilepsy syndrome	4.95e-05	0.000284	CcSEcCtD
Mitoxantrone—Discomfort—Gabapentin—epilepsy syndrome	4.95e-05	0.000284	CcSEcCtD
Mitoxantrone—Headache—Oxcarbazepine—epilepsy syndrome	4.93e-05	0.000283	CcSEcCtD
Mitoxantrone—Nausea—Zonisamide—epilepsy syndrome	4.9e-05	0.000281	CcSEcCtD
Mitoxantrone—Hypotension—Pregabalin—epilepsy syndrome	4.89e-05	0.000281	CcSEcCtD
Mitoxantrone—Dysgeusia—Topiramate—epilepsy syndrome	4.85e-05	0.000278	CcSEcCtD
Mitoxantrone—Confusional state—Gabapentin—epilepsy syndrome	4.84e-05	0.000278	CcSEcCtD
Mitoxantrone—Oedema—Gabapentin—epilepsy syndrome	4.8e-05	0.000276	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.8e-05	0.000276	CcSEcCtD
Mitoxantrone—Vomiting—Carbamazepine—epilepsy syndrome	4.8e-05	0.000275	CcSEcCtD
Mitoxantrone—Back pain—Topiramate—epilepsy syndrome	4.79e-05	0.000275	CcSEcCtD
Mitoxantrone—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.77e-05	0.000274	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.77e-05	0.000274	CcSEcCtD
Mitoxantrone—Infection—Gabapentin—epilepsy syndrome	4.77e-05	0.000274	CcSEcCtD
Mitoxantrone—Rash—Carbamazepine—epilepsy syndrome	4.76e-05	0.000273	CcSEcCtD
Mitoxantrone—Dermatitis—Carbamazepine—epilepsy syndrome	4.75e-05	0.000273	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.74e-05	0.000272	CcSEcCtD
Mitoxantrone—Nausea—Clonazepam—epilepsy syndrome	4.73e-05	0.000271	CcSEcCtD
Mitoxantrone—Headache—Carbamazepine—epilepsy syndrome	4.73e-05	0.000271	CcSEcCtD
Mitoxantrone—Shock—Gabapentin—epilepsy syndrome	4.73e-05	0.000271	CcSEcCtD
Mitoxantrone—Paraesthesia—Pregabalin—epilepsy syndrome	4.7e-05	0.00027	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.7e-05	0.00027	CcSEcCtD
Mitoxantrone—Nausea—Phenytoin—epilepsy syndrome	4.7e-05	0.000269	CcSEcCtD
Mitoxantrone—Tachycardia—Gabapentin—epilepsy syndrome	4.69e-05	0.000269	CcSEcCtD
Mitoxantrone—Dyspnoea—Pregabalin—epilepsy syndrome	4.67e-05	0.000268	CcSEcCtD
Mitoxantrone—Nausea—Oxcarbazepine—epilepsy syndrome	4.67e-05	0.000268	CcSEcCtD
Mitoxantrone—Vision blurred—Topiramate—epilepsy syndrome	4.67e-05	0.000268	CcSEcCtD
Mitoxantrone—Skin disorder—Gabapentin—epilepsy syndrome	4.67e-05	0.000268	CcSEcCtD
Mitoxantrone—Somnolence—Pregabalin—epilepsy syndrome	4.66e-05	0.000267	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.64e-05	0.000266	CcSEcCtD
Mitoxantrone—Vomiting—Lamotrigine—epilepsy syndrome	4.64e-05	0.000266	CcSEcCtD
Mitoxantrone—Urticaria—Valproic Acid—epilepsy syndrome	4.6e-05	0.000264	CcSEcCtD
Mitoxantrone—Rash—Lamotrigine—epilepsy syndrome	4.6e-05	0.000264	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Topiramate—epilepsy syndrome	4.59e-05	0.000264	CcSEcCtD
Mitoxantrone—Dermatitis—Lamotrigine—epilepsy syndrome	4.59e-05	0.000264	CcSEcCtD
Mitoxantrone—Abdominal pain—Valproic Acid—epilepsy syndrome	4.58e-05	0.000263	CcSEcCtD
Mitoxantrone—Body temperature increased—Valproic Acid—epilepsy syndrome	4.58e-05	0.000263	CcSEcCtD
Mitoxantrone—Anorexia—Gabapentin—epilepsy syndrome	4.58e-05	0.000263	CcSEcCtD
Mitoxantrone—Anaemia—Topiramate—epilepsy syndrome	4.58e-05	0.000263	CcSEcCtD
Mitoxantrone—Headache—Lamotrigine—epilepsy syndrome	4.57e-05	0.000262	CcSEcCtD
Mitoxantrone—Decreased appetite—Pregabalin—epilepsy syndrome	4.55e-05	0.000261	CcSEcCtD
Mitoxantrone—Fatigue—Pregabalin—epilepsy syndrome	4.52e-05	0.000259	CcSEcCtD
Mitoxantrone—Hypotension—Gabapentin—epilepsy syndrome	4.49e-05	0.000258	CcSEcCtD
Mitoxantrone—Nausea—Carbamazepine—epilepsy syndrome	4.48e-05	0.000257	CcSEcCtD
Mitoxantrone—Pain—Pregabalin—epilepsy syndrome	4.48e-05	0.000257	CcSEcCtD
Mitoxantrone—Constipation—Pregabalin—epilepsy syndrome	4.48e-05	0.000257	CcSEcCtD
Mitoxantrone—Malaise—Topiramate—epilepsy syndrome	4.47e-05	0.000256	CcSEcCtD
Mitoxantrone—Leukopenia—Topiramate—epilepsy syndrome	4.43e-05	0.000254	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.38e-05	0.000251	CcSEcCtD
Mitoxantrone—Nausea—Lamotrigine—epilepsy syndrome	4.33e-05	0.000249	CcSEcCtD
Mitoxantrone—Cough—Topiramate—epilepsy syndrome	4.32e-05	0.000248	CcSEcCtD
Mitoxantrone—Feeling abnormal—Pregabalin—epilepsy syndrome	4.32e-05	0.000248	CcSEcCtD
Mitoxantrone—Paraesthesia—Gabapentin—epilepsy syndrome	4.31e-05	0.000248	CcSEcCtD
Mitoxantrone—Convulsion—Topiramate—epilepsy syndrome	4.29e-05	0.000246	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.28e-05	0.000246	CcSEcCtD
Mitoxantrone—Dyspnoea—Gabapentin—epilepsy syndrome	4.28e-05	0.000246	CcSEcCtD
Mitoxantrone—Hypertension—Topiramate—epilepsy syndrome	4.28e-05	0.000245	CcSEcCtD
Mitoxantrone—Somnolence—Gabapentin—epilepsy syndrome	4.27e-05	0.000245	CcSEcCtD
Mitoxantrone—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.27e-05	0.000245	CcSEcCtD
Mitoxantrone—Dyspepsia—Gabapentin—epilepsy syndrome	4.23e-05	0.000243	CcSEcCtD
Mitoxantrone—Chest pain—Topiramate—epilepsy syndrome	4.22e-05	0.000242	CcSEcCtD
Mitoxantrone—Myalgia—Topiramate—epilepsy syndrome	4.22e-05	0.000242	CcSEcCtD
Mitoxantrone—Arthralgia—Topiramate—epilepsy syndrome	4.22e-05	0.000242	CcSEcCtD
Mitoxantrone—Anxiety—Topiramate—epilepsy syndrome	4.2e-05	0.000241	CcSEcCtD
Mitoxantrone—Decreased appetite—Gabapentin—epilepsy syndrome	4.18e-05	0.00024	CcSEcCtD
Mitoxantrone—Discomfort—Topiramate—epilepsy syndrome	4.17e-05	0.000239	CcSEcCtD
Mitoxantrone—Urticaria—Pregabalin—epilepsy syndrome	4.16e-05	0.000239	CcSEcCtD
Mitoxantrone—Asthenia—Valproic Acid—epilepsy syndrome	4.16e-05	0.000239	CcSEcCtD
Mitoxantrone—Fatigue—Gabapentin—epilepsy syndrome	4.14e-05	0.000238	CcSEcCtD
Mitoxantrone—Abdominal pain—Pregabalin—epilepsy syndrome	4.14e-05	0.000238	CcSEcCtD
Mitoxantrone—Body temperature increased—Pregabalin—epilepsy syndrome	4.14e-05	0.000238	CcSEcCtD
Mitoxantrone—Constipation—Gabapentin—epilepsy syndrome	4.11e-05	0.000236	CcSEcCtD
Mitoxantrone—Pain—Gabapentin—epilepsy syndrome	4.11e-05	0.000236	CcSEcCtD
Mitoxantrone—Confusional state—Topiramate—epilepsy syndrome	4.07e-05	0.000234	CcSEcCtD
Mitoxantrone—Oedema—Topiramate—epilepsy syndrome	4.04e-05	0.000232	CcSEcCtD
Mitoxantrone—Infection—Topiramate—epilepsy syndrome	4.01e-05	0.00023	CcSEcCtD
Mitoxantrone—Shock—Topiramate—epilepsy syndrome	3.98e-05	0.000228	CcSEcCtD
Mitoxantrone—Diarrhoea—Valproic Acid—epilepsy syndrome	3.96e-05	0.000227	CcSEcCtD
Mitoxantrone—Feeling abnormal—Gabapentin—epilepsy syndrome	3.96e-05	0.000227	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Topiramate—epilepsy syndrome	3.96e-05	0.000227	CcSEcCtD
Mitoxantrone—Tachycardia—Topiramate—epilepsy syndrome	3.94e-05	0.000226	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.93e-05	0.000225	CcSEcCtD
Mitoxantrone—Skin disorder—Topiramate—epilepsy syndrome	3.93e-05	0.000225	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Topiramate—epilepsy syndrome	3.91e-05	0.000224	CcSEcCtD
Mitoxantrone—Hypersensitivity—Pregabalin—epilepsy syndrome	3.86e-05	0.000221	CcSEcCtD
Mitoxantrone—Anorexia—Topiramate—epilepsy syndrome	3.85e-05	0.000221	CcSEcCtD
Mitoxantrone—Urticaria—Gabapentin—epilepsy syndrome	3.82e-05	0.000219	CcSEcCtD
Mitoxantrone—Abdominal pain—Gabapentin—epilepsy syndrome	3.8e-05	0.000218	CcSEcCtD
Mitoxantrone—Body temperature increased—Gabapentin—epilepsy syndrome	3.8e-05	0.000218	CcSEcCtD
Mitoxantrone—Hypotension—Topiramate—epilepsy syndrome	3.78e-05	0.000217	CcSEcCtD
Mitoxantrone—Asthenia—Pregabalin—epilepsy syndrome	3.76e-05	0.000216	CcSEcCtD
Mitoxantrone—Vomiting—Valproic Acid—epilepsy syndrome	3.68e-05	0.000211	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.68e-05	0.000211	CcSEcCtD
Mitoxantrone—Rash—Valproic Acid—epilepsy syndrome	3.65e-05	0.00021	CcSEcCtD
Mitoxantrone—Dermatitis—Valproic Acid—epilepsy syndrome	3.65e-05	0.000209	CcSEcCtD
Mitoxantrone—Headache—Valproic Acid—epilepsy syndrome	3.63e-05	0.000208	CcSEcCtD
Mitoxantrone—Paraesthesia—Topiramate—epilepsy syndrome	3.63e-05	0.000208	CcSEcCtD
Mitoxantrone—Dyspnoea—Topiramate—epilepsy syndrome	3.6e-05	0.000207	CcSEcCtD
Mitoxantrone—Somnolence—Topiramate—epilepsy syndrome	3.59e-05	0.000206	CcSEcCtD
Mitoxantrone—Diarrhoea—Pregabalin—epilepsy syndrome	3.58e-05	0.000206	CcSEcCtD
Mitoxantrone—Dyspepsia—Topiramate—epilepsy syndrome	3.56e-05	0.000204	CcSEcCtD
Mitoxantrone—Hypersensitivity—Gabapentin—epilepsy syndrome	3.54e-05	0.000203	CcSEcCtD
Mitoxantrone—Decreased appetite—Topiramate—epilepsy syndrome	3.51e-05	0.000202	CcSEcCtD
Mitoxantrone—Fatigue—Topiramate—epilepsy syndrome	3.48e-05	0.0002	CcSEcCtD
Mitoxantrone—Pain—Topiramate—epilepsy syndrome	3.46e-05	0.000198	CcSEcCtD
Mitoxantrone—Constipation—Topiramate—epilepsy syndrome	3.46e-05	0.000198	CcSEcCtD
Mitoxantrone—Asthenia—Gabapentin—epilepsy syndrome	3.45e-05	0.000198	CcSEcCtD
Mitoxantrone—Nausea—Valproic Acid—epilepsy syndrome	3.44e-05	0.000197	CcSEcCtD
Mitoxantrone—Vomiting—Pregabalin—epilepsy syndrome	3.33e-05	0.000191	CcSEcCtD
Mitoxantrone—Feeling abnormal—Topiramate—epilepsy syndrome	3.33e-05	0.000191	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.3e-05	0.00019	CcSEcCtD
Mitoxantrone—Rash—Pregabalin—epilepsy syndrome	3.3e-05	0.00019	CcSEcCtD
Mitoxantrone—Dermatitis—Pregabalin—epilepsy syndrome	3.3e-05	0.000189	CcSEcCtD
Mitoxantrone—Diarrhoea—Gabapentin—epilepsy syndrome	3.29e-05	0.000189	CcSEcCtD
Mitoxantrone—Headache—Pregabalin—epilepsy syndrome	3.28e-05	0.000188	CcSEcCtD
Mitoxantrone—Urticaria—Topiramate—epilepsy syndrome	3.21e-05	0.000184	CcSEcCtD
Mitoxantrone—Body temperature increased—Topiramate—epilepsy syndrome	3.19e-05	0.000183	CcSEcCtD
Mitoxantrone—Abdominal pain—Topiramate—epilepsy syndrome	3.19e-05	0.000183	CcSEcCtD
Mitoxantrone—Nausea—Pregabalin—epilepsy syndrome	3.11e-05	0.000179	CcSEcCtD
Mitoxantrone—Vomiting—Gabapentin—epilepsy syndrome	3.05e-05	0.000175	CcSEcCtD
Mitoxantrone—Rash—Gabapentin—epilepsy syndrome	3.03e-05	0.000174	CcSEcCtD
Mitoxantrone—Dermatitis—Gabapentin—epilepsy syndrome	3.03e-05	0.000174	CcSEcCtD
Mitoxantrone—Headache—Gabapentin—epilepsy syndrome	3.01e-05	0.000173	CcSEcCtD
Mitoxantrone—Hypersensitivity—Topiramate—epilepsy syndrome	2.98e-05	0.000171	CcSEcCtD
Mitoxantrone—Asthenia—Topiramate—epilepsy syndrome	2.9e-05	0.000166	CcSEcCtD
Mitoxantrone—Nausea—Gabapentin—epilepsy syndrome	2.85e-05	0.000164	CcSEcCtD
Mitoxantrone—Diarrhoea—Topiramate—epilepsy syndrome	2.77e-05	0.000159	CcSEcCtD
Mitoxantrone—Vomiting—Topiramate—epilepsy syndrome	2.57e-05	0.000147	CcSEcCtD
Mitoxantrone—Rash—Topiramate—epilepsy syndrome	2.55e-05	0.000146	CcSEcCtD
Mitoxantrone—Dermatitis—Topiramate—epilepsy syndrome	2.55e-05	0.000146	CcSEcCtD
Mitoxantrone—Headache—Topiramate—epilepsy syndrome	2.53e-05	0.000145	CcSEcCtD
Mitoxantrone—Nausea—Topiramate—epilepsy syndrome	2.4e-05	0.000138	CcSEcCtD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.01e-05	0.000124	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—STXBP1—epilepsy syndrome	1.01e-05	0.000123	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGF2—epilepsy syndrome	9.99e-06	0.000122	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.94e-06	0.000121	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—KCNJ11—epilepsy syndrome	9.91e-06	0.000121	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CHRM3—epilepsy syndrome	9.91e-06	0.000121	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NT5E—epilepsy syndrome	9.84e-06	0.00012	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALAD—epilepsy syndrome	9.84e-06	0.00012	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	9.84e-06	0.00012	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—KCNB1—epilepsy syndrome	9.78e-06	0.000119	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	9.78e-06	0.000119	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	9.78e-06	0.000119	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PFKL—epilepsy syndrome	9.78e-06	0.000119	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	9.78e-06	0.000119	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—BCL2—epilepsy syndrome	9.49e-06	0.000116	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	9.44e-06	0.000115	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALDH7A1—epilepsy syndrome	9.39e-06	0.000114	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CACNA1A—epilepsy syndrome	9.39e-06	0.000114	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	9.33e-06	0.000114	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—RELA—epilepsy syndrome	9.28e-06	0.000113	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ST3GAL3—epilepsy syndrome	9.19e-06	0.000112	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ABCG2—epilepsy syndrome	9.18e-06	0.000112	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MTOR—epilepsy syndrome	9.1e-06	0.000111	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	9.09e-06	0.000111	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ADSL—epilepsy syndrome	9e-06	0.00011	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP2C19—epilepsy syndrome	8.95e-06	0.000109	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—UPB1—epilepsy syndrome	8.95e-06	0.000109	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NEU1—epilepsy syndrome	8.95e-06	0.000109	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ATIC—epilepsy syndrome	8.95e-06	0.000109	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	8.9e-06	0.000108	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP11A1—epilepsy syndrome	8.89e-06	0.000108	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ABCG2—epilepsy syndrome	8.88e-06	0.000108	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.83e-06	0.000108	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GLUL—epilepsy syndrome	8.83e-06	0.000108	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SLC2A1—epilepsy syndrome	8.67e-06	0.000106	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CACNA1D—epilepsy syndrome	8.67e-06	0.000106	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP2C19—epilepsy syndrome	8.66e-06	0.000106	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	8.61e-06	0.000105	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—JUNB—epilepsy syndrome	8.6e-06	0.000105	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP11A1—epilepsy syndrome	8.6e-06	0.000105	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS1—epilepsy syndrome	8.54e-06	0.000104	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.54e-06	0.000104	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	8.45e-06	0.000103	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL1B—epilepsy syndrome	8.39e-06	0.000102	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	8.32e-06	0.000101	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GBE1—epilepsy syndrome	8.32e-06	0.000101	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HBEGF—epilepsy syndrome	8.15e-06	9.93e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—JUN—epilepsy syndrome	8.13e-06	9.91e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TXNRD1—epilepsy syndrome	8.11e-06	9.88e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.05e-06	9.81e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP2D6—epilepsy syndrome	8.03e-06	9.78e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	8.02e-06	9.78e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT3—epilepsy syndrome	8e-06	9.75e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	7.95e-06	9.69e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	7.95e-06	9.69e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—FAR1—epilepsy syndrome	7.95e-06	9.69e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CERS1—epilepsy syndrome	7.95e-06	9.69e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ADK—epilepsy syndrome	7.95e-06	9.69e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PDXK—epilepsy syndrome	7.95e-06	9.69e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP2C19—epilepsy syndrome	7.87e-06	9.6e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AQP1—epilepsy syndrome	7.87e-06	9.59e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP11A1—epilepsy syndrome	7.83e-06	9.54e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ASAH1—epilepsy syndrome	7.82e-06	9.53e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ADAM10—epilepsy syndrome	7.81e-06	9.52e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.79e-06	9.49e-05	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—AKT1—epilepsy syndrome	7.78e-06	9.48e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP2D6—epilepsy syndrome	7.76e-06	9.46e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	7.73e-06	9.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.65e-06	9.33e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ADRA2A—epilepsy syndrome	7.64e-06	9.31e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—BCHE—epilepsy syndrome	7.61e-06	9.28e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—STXBP1—epilepsy syndrome	7.61e-06	9.27e-05	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—AKT1—epilepsy syndrome	7.47e-06	9.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	7.45e-06	9.08e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NT5E—epilepsy syndrome	7.41e-06	9.04e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALAD—epilepsy syndrome	7.41e-06	9.04e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ADRA2A—epilepsy syndrome	7.39e-06	9.01e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.37e-06	8.99e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—BCHE—epilepsy syndrome	7.36e-06	8.97e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDC42—epilepsy syndrome	7.3e-06	8.9e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—SRC—epilepsy syndrome	7.29e-06	8.89e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.27e-06	8.86e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.27e-06	8.86e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.27e-06	8.86e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.27e-06	8.86e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SLC2A1—epilepsy syndrome	7.26e-06	8.85e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	7.23e-06	8.82e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PLCB1—epilepsy syndrome	7.18e-06	8.75e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TH—epilepsy syndrome	7.15e-06	8.72e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CHRM3—epilepsy syndrome	7.12e-06	8.67e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—KCNJ11—epilepsy syndrome	7.12e-06	8.67e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	7.07e-06	8.62e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	7.07e-06	8.62e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	7.06e-06	8.61e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.04e-06	8.58e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SLC2A1—epilepsy syndrome	7.02e-06	8.56e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PLCB1—epilepsy syndrome	6.94e-06	8.46e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	6.92e-06	8.44e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TH—epilepsy syndrome	6.92e-06	8.43e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.81e-06	8.3e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ADSL—epilepsy syndrome	6.78e-06	8.26e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—QDPR—epilepsy syndrome	6.76e-06	8.24e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CA4—epilepsy syndrome	6.76e-06	8.24e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	6.74e-06	8.22e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.74e-06	8.21e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	6.72e-06	8.2e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—BCHE—epilepsy syndrome	6.7e-06	8.16e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HES1—epilepsy syndrome	6.68e-06	8.14e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GLUL—epilepsy syndrome	6.65e-06	8.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	6.53e-06	7.95e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FYN—epilepsy syndrome	6.5e-06	7.92e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	6.49e-06	7.91e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—H2AFX—epilepsy syndrome	6.47e-06	7.89e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	6.39e-06	7.79e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.36e-06	7.75e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	6.32e-06	7.7e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PLCB1—epilepsy syndrome	6.32e-06	7.7e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TH—epilepsy syndrome	6.3e-06	7.67e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—YWHAZ—epilepsy syndrome	6.25e-06	7.61e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	6.1e-06	7.44e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.06e-06	7.39e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.03e-06	7.35e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.03e-06	7.35e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.03e-06	7.35e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.03e-06	7.35e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.03e-06	7.35e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.01e-06	7.33e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CCR5—epilepsy syndrome	6.01e-06	7.32e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HMOX1—epilepsy syndrome	5.97e-06	7.28e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AQP1—epilepsy syndrome	5.93e-06	7.22e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CAT—epilepsy syndrome	5.89e-06	7.18e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	5.8e-06	7.07e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HMOX1—epilepsy syndrome	5.78e-06	7.04e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ABCB1—epilepsy syndrome	5.73e-06	6.99e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CAT—epilepsy syndrome	5.7e-06	6.95e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	5.65e-06	6.89e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	5.62e-06	6.85e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TSC2—epilepsy syndrome	5.59e-06	6.81e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ABCB1—epilepsy syndrome	5.54e-06	6.76e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.51e-06	6.72e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.51e-06	6.72e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.51e-06	6.72e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APOE—epilepsy syndrome	5.47e-06	6.66e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	5.42e-06	6.6e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	5.36e-06	6.53e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CHRM3—epilepsy syndrome	5.36e-06	6.53e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GPX1—epilepsy syndrome	5.33e-06	6.49e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.31e-06	6.47e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HMOX1—epilepsy syndrome	5.25e-06	6.4e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CAT—epilepsy syndrome	5.18e-06	6.32e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GPX1—epilepsy syndrome	5.15e-06	6.28e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6ST—epilepsy syndrome	5.13e-06	6.26e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.12e-06	6.25e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.12e-06	6.25e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS2—epilepsy syndrome	5.09e-06	6.21e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	5.07e-06	6.18e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ABCB1—epilepsy syndrome	5.04e-06	6.15e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	4.83e-06	5.88e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.82e-06	5.87e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—BCHE—epilepsy syndrome	4.81e-06	5.86e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GPX1—epilepsy syndrome	4.69e-06	5.71e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.69e-06	5.71e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AGT—epilepsy syndrome	4.67e-06	5.69e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	4.59e-06	5.59e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—APOE—epilepsy syndrome	4.58e-06	5.58e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.57e-06	5.57e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.57e-06	5.57e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	4.54e-06	5.53e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT1—epilepsy syndrome	4.53e-06	5.52e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TH—epilepsy syndrome	4.52e-06	5.51e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AGT—epilepsy syndrome	4.52e-06	5.51e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APOE—epilepsy syndrome	4.43e-06	5.4e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ABCG2—epilepsy syndrome	4.37e-06	5.33e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.36e-06	5.31e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.36e-06	5.31e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.26e-06	5.2e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	4.26e-06	5.19e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	4.23e-06	5.16e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.18e-06	5.09e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF2—epilepsy syndrome	4.15e-06	5.06e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AGT—epilepsy syndrome	4.11e-06	5.01e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.1e-06	4.99e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.03e-06	4.92e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOE—epilepsy syndrome	4.03e-06	4.91e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.02e-06	4.9e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—POMC—epilepsy syndrome	3.93e-06	4.79e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	3.82e-06	4.65e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—POMC—epilepsy syndrome	3.8e-06	4.64e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTOR—epilepsy syndrome	3.78e-06	4.61e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	3.77e-06	4.6e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.76e-06	4.58e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—epilepsy syndrome	3.75e-06	4.57e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CAT—epilepsy syndrome	3.72e-06	4.54e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.65e-06	4.45e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.64e-06	4.44e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	3.64e-06	4.43e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	3.62e-06	4.41e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—BCHE—epilepsy syndrome	3.62e-06	4.41e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALB—epilepsy syndrome	3.59e-06	4.37e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALB—epilepsy syndrome	3.47e-06	4.23e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—POMC—epilepsy syndrome	3.46e-06	4.22e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.45e-06	4.21e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.42e-06	4.16e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TH—epilepsy syndrome	3.4e-06	4.15e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GPX1—epilepsy syndrome	3.37e-06	4.1e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.3e-06	4.02e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.3e-06	4.02e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALB—epilepsy syndrome	3.15e-06	3.85e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—epilepsy syndrome	3.14e-06	3.82e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—epilepsy syndrome	3.03e-06	3.7e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SRC—epilepsy syndrome	3.03e-06	3.69e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AGT—epilepsy syndrome	2.95e-06	3.6e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOE—epilepsy syndrome	2.89e-06	3.53e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.84e-06	3.46e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CAT—epilepsy syndrome	2.8e-06	3.42e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—epilepsy syndrome	2.76e-06	3.36e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.69e-06	3.28e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.62e-06	3.2e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.61e-06	3.18e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.53e-06	3.09e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—POMC—epilepsy syndrome	2.48e-06	3.03e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.35e-06	2.87e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALB—epilepsy syndrome	2.27e-06	2.76e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.24e-06	2.73e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.23e-06	2.72e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AGT—epilepsy syndrome	2.22e-06	2.71e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOE—epilepsy syndrome	2.18e-06	2.65e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.13e-06	2.59e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.1e-06	2.57e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TH—epilepsy syndrome	2.1e-06	2.56e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	1.98e-06	2.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT1—epilepsy syndrome	1.88e-06	2.29e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—POMC—epilepsy syndrome	1.87e-06	2.28e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.75e-06	2.13e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.73e-06	2.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALB—epilepsy syndrome	1.71e-06	2.08e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.68e-06	2.05e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKT1—epilepsy syndrome	1.58e-06	1.92e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.56e-06	1.9e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKT1—epilepsy syndrome	1.52e-06	1.86e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.49e-06	1.82e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.39e-06	1.69e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.37e-06	1.67e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.34e-06	1.64e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.15e-06	1.4e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.05e-06	1.28e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKT1—epilepsy syndrome	9.96e-07	1.21e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.19e-07	1.12e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKT1—epilepsy syndrome	7.5e-07	9.14e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.62e-07	5.63e-06	CbGpPWpGaD
